<DOC>
	<DOC>NCT03084744</DOC>
	<brief_summary>To compare the efficacy of schema therapy versus active monitoring for women with chronic depression receiving psychiatric care.</brief_summary>
	<brief_title>Schema Therapy for Chronic Depression</brief_title>
	<detailed_description>A randomized, assessor-blind, single center, superiority trial will be conducted. Participants will be referred to clinical psychologists in a private counseling office (Senzoku Stress Coping Support Office, in Japan). Eligible participants will be women with chronic depression receiving psychiatric care. Participants will receive schema therapy or active monitoring during 2 years. Primary outcome will be treatment response. A total sample size of 64 (32 in each group) would be required to provide 80% power at a 2-sided significance level of 5% to detect a risk difference of 35% (response rate: 55% for schema therapy vs. 20% for active monitoring), assuming a dropout rate of 10%.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Dysthymic Disorder</mesh_term>
	<criteria>Persistent depressive disorder including chronic major depressive disorder and dysthymic disorder assessed by the Structured Clinical Interview for DSM Scores of at least 14 on the GRIDHAMD Psychiatric treatment duration for depression of at least 3 years Psychiatric hospitalization within 30 days prior to the enrollment Ineligible to receive the protocol treatment during 2 years Schizophrenia Bipolar disorders Intellectual disabilities Neurocognitive disorders Substancerelated disorders</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>